Analyst · Moderna, Inc. (MRNA) | Ratings, Price Targets & Consensus

Analyst Consensus

Hold25 analysts

Hold

Updated Aug 6, 2026

Total Analysts25

Buy

7

Hold

16

Sell

4

Ratings

Updated Aug 6, 2026

Overall Rating

C-

DCF Score1.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$53.86

Median Target-31.01%

$37.16

Potential downside vs current price

DCF Value-103.26%

-$1.76

Potential downside vs current price

Current Stock Price

$53.86

Median Target-31.01%

$37.16

Potential downside vs current price

DCF Value-103.26%

-$1.76

Potential downside vs current price

Analyst Consensus

Hold25 analysts

Hold

Updated Aug 6, 2026

Total Analysts25

Buy

7

Hold

16

Sell

4

Ratings

Updated Aug 6, 2026

Overall Rating

C-

DCF Score1.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$53.86

Median Target-31.01%

$37.16

Potential downside vs current price

DCF Value-103.26%

-$1.76

Potential downside vs current price

Current Stock Price

$53.86

Median Target-31.01%

$37.16

Potential downside vs current price

DCF Value-103.26%

-$1.76

Potential downside vs current price